In Vitro Recombination of Non-Homologous Genes Can Result in Gene Fusions that Confer a Switching Phenotype to Cells by Heins, Richard A. et al.
In Vitro Recombination of Non-Homologous Genes Can
Result in Gene Fusions that Confer a Switching
Phenotype to Cells
Richard A. Heins
.¤a, Jay H. Choi
., Takayuki Sohka
¤b, Marc Ostermeier*
Department of Chemical & Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, United States of America
Abstract
Regulation of protein activity is central to the complexity of life. The ability to regulate protein activity through exogenously
added molecules has biotechnological/biomedical applications and offers tools for basic science. Such regulation can be
achieved by establishing a means to modulate the specific activity of the protein (i.e. allostery). An alternative strategy for
intracellular regulation of protein activity is to control the amount of protein through effects on its production,
accumulation, and degradation. We have previously demonstrated that the non-homologous recombination of the genes
encoding maltose binding protein (MBP) and TEM1 b-lactamase (BLA) can result in fusion proteins in which b-lactamase
enzyme activity is allosterically regulated by maltose. Here, through use of a two-tiered genetic selection scheme, we
demonstrate that such recombination can result in genes that confer maltose-dependent resistance to b-lactam even
though they do not encode allosteric enzymes. These ‘phenotypic switch’ genes encode fusion proteins whose
accumulation is a result of a specific interaction with maltose. Phenotypic switches represent an important class of proteins
for basic science and biotechnological applications in vivo.
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Introduction
The regulation of cellular protein activity occurs through many
mechanisms including the regulation of production (i.e. transcrip-
tion/translation), the targeting to specific cellular compartments,
the interaction with other molecules (i.e. inhibitors, activators, and
allosteric effectors) and the regulation of degradation. The direct
regulation of protein activity at the protein level through allosteric
effects offers two important advantages: regulation does not
depend on any other cellular components besides the effector
molecule and the regulation can be executed on much shorter
time scales – essentially instantaneously. These advantages have
motivated the engineering of synthetic switchable proteins for
biotechnological, biomedical and basic science applications [1].
One approach to the engineering of such protein switches is to
create fusions of proteins having the prerequisite input and output
functions of the desired switch. The key design question for this
approach is how to fuse two proteins such that binding of the
effector to the input domain modulates the activity of the output
domain. We have pursued a directed evolution approach to this
design problem, creating libraries of random insertions of one
domain into the other and using random circular permutation of
the inserted domain to vary the fusion location [2,3,4]. Such an
approach requires a well-designed selection/screening method in
order to find those rare protein switches among the majority of
constructs that lack effector-dependent activity. Genetic selections
are a powerful tool in this regard. For the selection of switches, one
needs to connect the modulation of the switches activity to a
selectable phenotype. However, since regulation of cellular protein
activity can occur by many mechanisms other than effector-
induced modulation of a protein’s specific activity, such selections
might result in the identification of gene fusions that confer
switching behavior to cells by means other than allostery.
We have previously described the use of a genetic circuit that
functions like a band-pass filter for enzyme activity to isolate
allosteric b-lactamase enzymes [5]. We subjected a library in
which random circular permutations of TEM1 b-lactamase gene
were inserted in place of codon 317 of the gene encoding E. coli
MBP to a two-tier selection designed to identify allosteric b-
lactamases that had maltose as an effector. In the first tier, the
library was challenged to grow on plates containing high
concentrations of ampicillin (Amp) and 10 mM maltose. Cells
surviving this positive selection were recovered en masse and, in the
second tier of the selection, challenged to grow in the absence of
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unusual type of selection, which was created using a synthetic
gene network, allows the researcher to select for cells that have b-
lactamase activity between two threshold values, much like an
electronic band-pass filter is designed to function to isolate
frequencies in a desired range. Selection against cells with high
b-lactamase activity results from placing a tetracycline resistance
gene downstream from the ampC promoter, which is induced by
low levels of b-lactam antibiotics, and challenging the bacteria to
grow in the presence of tetracycline. In this way, cells with high b-
lactamase activity degrade all the b-lactam antibiotic, lack
tetracycline resistance and can be selected against. This second
tier selection was performed in the absence of maltose to select for
those library members that confer low levels of b-lactamase
activity in the absence of maltose. Of the 34 colonies that survived
the second selection, four contained allosteric b-lactamases that
had maltose as an effector. This allostery was established by in vitro
experiments on the purified protein [2]. The remaining 30
colonies did not appear to contain allosteric enzymes as judged by
colorimetric assays on cell lysates for b-lactamase activity in the
presence and absence of maltose. However, most of these colonies
were not false positives for conferring a switching phenotype to
cells, as the gene fusions of these library members conferred to E.
coli an increase in Amp resistance in the presence of maltose – the
phenotype that should be necessary to survive both tiers of the
selection. We show here that all of these proteins, which we
describe as phenotypic switches, accumulate at higher concentra-
tions in the cell in the presence of maltose. We characterize this
phenomenon by examining the cellular accumulation, enzymatic
activity, and melting temperature of these phenotypic switches.
Evidence indicates that this phenotype manifests not from effects
on transcription but rather from the specific interaction of maltose
with the fusion protein that results in increased accumulation of
the protein.
Results
Identification of phenotypic switches and a control
non-switch
Using a two-tiered genetic selection designed to identify
allosteric b-lactamases that are activated by maltose, we isolated
34 library members from a library in which random circular
permutations of TEM1 b-lactamase gene were inserted in place of
codon 317 of the gene encoding E. coli MBP [5]. Four library
members harbored enzymes with the desired allosteric property.
The lysates of the remaining 30 colonies exhibited b-lactamase
activity that did not change upon the addition of maltose.
However, 28 of these library members had a .2-fold higher
ampicillin minimum inhibitory concentration (MICAmp) when the
cells were grown in liquid culture in the presence of maltose
compared to its absence. Maltose did not alter the MICAmp of
control cells expressing wildtype BLA, less-active mutants of BLA
or no b-lactamase gene. From initial attempts to sequence these
library members, it was determined that all 28 contained more
than one library plasmid (a not uncommon occurrence in large
libraries [6]). Therefore, plasmid DNA from each clone was
isolated and transformed into DH5a-E cells. Selection at low Amp
concentrations facilitated the isolation of the plasmids that
conferred the desired maltose-dependent MICAmp phenotype, as
most of the ‘‘extra’’ plasmids were comprised of out-of-frame
insertions of the bla gene. Subsequent sequencing revealed 13
unique sequences (Table 1) with many sequences isolated multiple
times.
These 13 library members were retransformed into RH22 cells
and their ability to confer maltose-dependent MICAmp tested in
5 ml liquid culture. All conferred a maltose-dependent resistance
to Amp with maltose increasing the MICAmp by 4-fold to 64-fold
(Table 2). We refer to these library members as phenotypic
switches, since they confer a MICAmp switching phenotype that
depends on maltose.
Ph8 was chosen as a representative phenotypic switch for
further characterization. For comparison, we desired a control
fusion protein of BLA and MBP that conferred ampicillin
resistance in a maltose-independent fashion. Such library
members were readily identified by screening colonies after the
first tier of the selection. We sequenced one of these library
members and named it c4 (Table 1). As an additional control we
chose MBP317-347, one of the allosteric enzymes previously
isolated from the same library [2,5].
Maltose increases the steady state protein levels of
soluble phenotypic switches but not through
transcriptional effects
Unlike MBP317-347, which exhibits a 150-fold increase in b-
lactamase activity when maltose is added to lysates expressing this
allosteric switch [2], the b-lactamase activity in the lysates of these
13 members was maltose-independent. This indicated that these
proteins were not allosteric enzymes. A possible explanation for
how these genes could confer an increase in MICAmp in the
presence of maltose was increased accumulation of active protein.
Thus, the effect of maltose on the accumulation of soluble fusion
protein was examined by western blot using anti-BLA antibodies.
Accumulation levels of fusion protein in the presence and absence
of maltose were determined under the same culture conditions as
the MIC assays. The accumulation of phenotypic switch Ph8 but
not the control BLA was markedly increased by the presence of
maltose in the growth media (Fig. 1A). Interestingly, allosteric
switch MBP317-347 also showed a dramatic increase in
accumulation in the presence of maltose (Fig. 1A), raising the
question of how much of its 16- to 32-fold increase in MICAmp in
the presence of maltose is a result of allosteric effects and how
Table 1. Sequence of fusion proteins.
Protein Protein Sequence
a
MBP317-347 MBP[1-316]-BLA[170-286]-DKS-BLA[24-170]-MBP[318-370]
Ph1 MBP[1-316]-BLA[263-286]-DKS-BLA[24-263]-MBP[318-370]
Ph3 MBP[1-316]-BLA[112-286]-DKS-BLA[24-114]-T-MBP[319-370]
Ph5 MBP[1-316]-BLA[267-286]-DKS-BLA[24-266]-MBP[318-370]
Ph7 MBP[1-316]-BLA[24-286]-MBP[318-370]
Ph8 MBP[1-316]-BLA[264-286]-DKS-BLA[24-263]-MBP[318-370]
Ph12 MBP[1-316]-BLA[260-286]-DKS-BLA[24-263]-MBP[318-370]
Ph14 MBP[1-316]-BLA[286]-DKS-BLA[24-286]-MBP[318-370]
Ph16 MBP[1-316]-BLA[24-286]-DKS-BLA[24]-MBP[318-370]
Ph17 MBP[1-316]-BLA[181-286]-DKS-BLA[24-191]-MBP[318-370]
Ph19 MBP[1-316]-BLA[194-286]-DKS-BLA[24-194]-MBP[318-370]
Ph24 MBP[1-316]-BLA[168-286]-DKS-BLA[24-168]-E-MBP[319-370]
Ph27 MBP[1-316]-BLA[113-286]-DKS-BLA[24-113]-MBP[318-370]
Ph28 MBP[1-316]-BLA[40-286]-DKS-BLA[24-39]-MBP[318-370]
c4 MBP[1-316]-BLA[24-286]-DK-T-MBP[319-370]
aBased on gene sequencing.
doi:10.1371/journal.pone.0027302.t001
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cell. Maltose increased the accumulation of all 13 selected
members (Table 2). A significant correlation between the increase
in protein levels and the increase in MICAmp in the presence of
maltose (Fig. 1B) suggested that increased accumulation of the
fusion in the presence of maltose is the major cause of the maltose-
dependent MICAmp phenotype. The cause of the increased
accumulation is unlikely to be transcriptional in nature, since
maltose did not increase the accumulation of MBP or BLA when
the respective genes were downstream from the tac promoter – the
same promoter that controlled the expression of the switches
(Table 2). Maltose increased the accumulation of MBP expressed
from the chromosome as expected [7], but not when MBP was
expressed under the tac promoter on the plasmid (Table 2). C4
exhibited a highly-variable but low increase in accumulation in the
presence of maltose; however, this is equal to or lower than the
increase observed with any of the phenotypic switches.
The increase in soluble Ph8 and Ph14 does not correlate
with a decrease in insoluble protein
To investigate whether the absence of maltose caused the
phenotypic switches to misfold and aggregate, we analyzed the
soluble and insoluble fractions of Ph8 and Ph14 by western blots.
Samples from cultures grown in the absence of maltose showed
very low amounts of soluble or insoluble protein, whereas samples
from cultures containing maltose showed an increase in both the
soluble and insoluble fractions (data not shown). Thus, the increase
in protein accumulation in the presence of maltose does not
appear to result from prevention of misfolding and aggregation.
Proteins chosen for in vitro characterization
For the remaining studies, Ph8 and c4 were selected for
purification and in vitro characterization. TEM1-BLA, MBP and
MBP317-347 [2] were purified as control proteins. We successfully
purified Ph8 and c4 using an amylose affinity column. This result
indicates that the insertion of BLA did not abolish their ability to
bind maltose since maltose was used to elute these proteins from
the column. This maintenance of maltose binding is consistent
Table 2. The effect of maltose on MICAmp and protein
expression.
MICAmp (mg/ml)
b Accumulation
c
Protein
a 2 Maltose + Maltose Ratio
d Ratio
d Stdev
e
None
f 111 2 . 4 0 . 2
MBP 1 1 1 1.0 0.1
BLA 8192 8192 1 1.3 0.1
MBP317-347 16–32 512 16–32 31.3 4.5
Ph1 32 512–1024 32–64 14.6 3.1
Ph3 256 1024–2048 4–8 10.7 1.0
Ph5 16–32 256–512 8–32 17.6 5.9
Ph7 32–64 1024 16–32 25.7 6.5
Ph8 32 512–1024 16–32 19.2 7.5
Ph12 64 1024–2048 16–32 38.9 10.1
Ph14 128 2048 16 12.4 6.8
Ph16 1024 4096 4 5.4 2.1
Ph17 32 1024 32 49.2 7.9
Ph19 256 2048 8 14.7 2.2
Ph24 4–8 128 32 21.5 4.7
Ph27 256 2048 8 11.1 3.7
Ph28 64 1024–2048 16–32 22.7 7.2
c4 1024–2048 2048 1–2 5.3 5.0
aProtein expressed from plasmid pDIMC8 in RH22 cells.
bMICAmp was determined in triplicate. For proteins with a MICAmp range, this
indicates the range from the three experiments (e.g. Ph5 was found to have a
MICAmp in the absence of maltose of 16 mg/ml in some trials and 32 mg/ml in
other trials).
cAccumulation ratio determined from quantitative image analysis of western
blots probed using polyclonal anti-BLA antibodies (except for MBP which was
probed with anti-MBP antibodies).
d(With maltose)/(without maltose).
eStandard deviation calculated from three independent experiments.
fNo pDIMC8 plasmid was present. The protein monitored by western blot was
chromosomally encoded MBP.
doi:10.1371/journal.pone.0027302.t002
Figure 1. Characterization of phenotypic switches. (A) Western
blot using anti-BLA antibodies of the soluble fraction of cells expressing
BLA (lower arrow, ,30 kDa), MBP317-347, c4, and Ph8 (all upper arrow,
,70 kDa) cultured in the presence (+) and absence (2)o f5 m M
maltose. (B) Correlation between the accumulation ratio (+maltose/
2maltose), as measured by western blot, and the MICAmp ratio
(+maltose/2maltose) of cell expressing the 13 phenotypic switches,
MBP317-347, c4 and BLA. The dotted line is y=x. Error bars represent
the standard deviation (N=3).
doi:10.1371/journal.pone.0027302.g001
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BLA in place of MBP residue 317 [2].
Neither Ph8 nor c4 are allosteric enzymes
We determined the Michaelis-Menten kinetic parameters for
Amp hydrolysis of purified Ph8 and c4 at 37uC (Table 3). The Km
and kcat for Amp for both proteins did not change upon the
addition of 5 mM maltose. c4 has similar catalytic properties to
TEM1-BLA [8,9], which is not too surprising considering the BLA
domain in this protein is essentially wild-type (i.e. it is not circularly
permuted) (Table 1). Ph8 has a 10-fold higher Km compared to
wild-type BLA, but a wild-type kcat. These kinetic studies confirm
that neither Ph8 nor c4 is an allosteric enzyme with maltose as an
effector.
Maltose-binding increases the melting temperature of
the Ph8 and c4 by equal amounts
The insertion of BLA into MBP can be a destabilizing event that
may result in a fusion protein with a lower melting temperature
than either of the two parental proteins. Conversely, the binding of
maltose to MBP is a stabilizing interaction with an increase in
melting temperature by about 8uC [10]. If the melting
temperature of the fusion was near or below the growth
temperature in the absence of maltose, but increased above the
growth temperature in the presence of maltose, this could account
for the increased accumulation in the presence of maltose.
Temperature-induced unfolding experiments were conducted
on MBP, BLA, MBP317-347, Ph8 and c4 to determine the
melting temperature (Tm) in the presence and absence of maltose.
We measured changes in ellipticity as a function of temperature by
circular dichroism spectroscopy. The presence of maltose
increased the Tm of MBP by 7.9uC (Table 4), in good agreement
with published values [10]. As expected, maltose had no effect on
the Tm of BLA, and our value for Tm (,52.5uC) closely matched
that of a previous study (50.1uC) [11]. MBP317-347, Ph8 and c4
all had significantly lower Tm values compared to MBP (a loss of
between 15 to 20uC), indicating that the insertion of the BLA
domain negatively affected their melting temperature. The low Tm
of MBP317-347 and Ph8 in the absence of maltose (only 8–10uC
above growth conditions of the bacteria) suggested that low
thermal stability could play a role in the reduced accumulation of
these proteins. The addition of maltose increased the Tm for both
of these proteins by about 10uC, offering a potential mechanism
for the increased accumulation of these proteins. However, c4’s
melting temperature in the presence and absence of maltose was
the same as the values for MBP317-347 and Ph8. Since Ph8 and
c4 had equivalent Tm’s yet only Ph8 conferred a switching
phenotype, a ligand-induced increase in melting temperature does
not necessarily confer a switching phenotype and may not be the
mechanism by which Ph8 confers a switching phenotype.
Osmolyte-protein interactions are not the cause of
increased production of phenotypic switches
Maltose and sucrose are known osmolytes [12] a class of
molecules known to shift the conformational equilibrium proteins
towards a folded state due to solvation interactions with the
peptide backbone. Osmolyte interactions are weak, typically
requiring millimolar to molar concentrations to effectively
influence protein folding [13]. Since the switching phenotype is
observed in experiments with 5 mM maltose in the growth media,
it was possible that this interaction was partially or wholly
responsible for the increased production of the phenotypic
switches. However, the addition of 5 mM maltose did not increase
the melting temperature of BLA, indicating that 5 mM maltose
does not appreciably stabilized BLA.
To determine whether maltose affected the phenotypic switches
by a specific ligand-protein interaction or a more general osmolyte
effect, we compared the effect of maltose and sucrose on the
production of MBP317-347, Ph8 and two variants of MBP317-347
(5–7 and MBP317-347-W340A). 5–7 is a quadruple mutant of
MBP317-347 that has both maltose and sucrose as allosteric
effectors [2]. This switch retains micromolar affinity for maltose
(apparent Kd, maltose=23mM), and its sucrose affinity has
increased by more than 10
6-fold relative to MBP317-347
(apparent Kd, sucrose=0.7 mM) [2]. MBP317-347 has fairly strong
maltose affinity (Kd=0.5 mM [2]), while the introduction of the
W340A mutation is known to reduce the maltose affinity of wild-
type MBP by about 1000-fold [14]. MBP317-347 was chosen as
the example phenotypic switch for these studies instead of Ph8
because (1) MBP317-347 is more characterized and (2) the
Table 3. Kinetic constants for the hydrolysis of ampicillin
a.
Protein Km (mM) kcat (S-1) kcat/Km ratio
c
2 Maltose + Maltose 2 Maltose + Maltose
Ph8 7306120 7006100 18706220 19506110 1.160.3
c4 73647 7 682 2 8 0 6120 23506110 1.060.1
BLA
b 32 2 1050 22
aAssays were at 37uC in 10 mM phosphate buffer (pH 7.0) with or without 5 mM maltose.
bAt 30uC in 50 mM phosphate buffer (pH 7.0) [9]. Previous studies have shown that BLA enzyme activity is unaffected by maltose [4].
c(kcat/Km)+maltose/(kcat/Km)2maltose.
doi:10.1371/journal.pone.0027302.t003
Table 4. Melting temperatures of proteins.
Tm (6C)
a
Protein 2 Maltose + Maltose
MBP 64.4 72.3
BLA 52.4 52.6
MBP317-347 44.6 54.3
Ph8 47.2 57.5
c4 46.4 56.4
aTm, temperature at transition midpoint, determined by temperature-induced
unfolding monitored by CD spectroscopy. All temperatures are 60.2uC.
doi:10.1371/journal.pone.0027302.t004
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MBP317-347 and it was uncertain whether such mutations would
work in Ph8.
We cultured cells expressing these proteins in the presence and
absence of different concentrations of maltose and sucrose. The
accumulation of soluble protein was compared by western blot.
The results indicate that a specific ligand-protein interaction and
not an osmolyte effect causes the increased accumulation. Only 5–
7 – the one switch with high affinity for sucrose – showed an
increase in production in the presence of sucrose (Fig. 2A). The
addition of the W340A mutation to MBP317-347 dramatically
impaired maltose’s ability to increase the MICAmp of cells
expressing the switch, requiring about 1000-fold higher maltose
concentrations for similar MICAmp increases (Fig. 2B). In addition,
both MBP317-347 and MBP317-347/W340A accumulation
increased with maltose concentration in a dose-dependent manner
(Fig. 2B). A detectable MICAmp increase for cells expressing
MBP371-347 required only 1 mM maltose (Fig. 2C), which is
inconsistent with the high concentrations needed for an osmolyte
effect. These experiments strongly suggest that a specific ligand-
protein interaction is essential for enhanced accumulation and that
any beneficial folding effects conferred by these osmolytes are
minimal with respect to the accumulation of protein.
Discussion
With one exception, the phenotypic switch genes conferred a
MICAmp above 200 mg/ml in the presence of maltose (Table 1).
This is consistent with the first tier of the selection that was used to
isolate them. However, in the absence of maltose, 5 of 13 of the
phenotypic switches conferred an MICAmp$128 mg/ml – higher
than expected since the second tier should select for library
members that confer an MICAmp of 16, 32 or 64 mg/ml [5]. We
speculate that the presence of two plasmids in the initially selected
library members – one encoding a phenotypic switch and one
encoding a non-functional b-lactamase – conferred a larger
difference in the maltose-dependent MICAmp through selective
pressure on the two plasmids. In the second tier of the selection, in
which cells were required to have low b-lactamase activity to
survive, cells in which the copy number of the plasmid encoding
the non-functional b-lactamase increased relative to that encoding
the phenotypic switch would have a selective advantage for
growing under the conditions of this selection. Such a change in
the relative copy number of the two library plasmids could occur
for stochastic reasons during cell division and lower the amount of
cellular b-lactamase activity enough to permit survival. This
theory is further supported by the fact that the maltose-dependent
differences in MICAmp were greater for some of the originally
isolated library members bearing both plasmids than for cells
bearing only the plasmid encoding the phenotypic switches.
The mechanism by which maltose causes an increase in the
accumulation of the phenotypic switches is not clear. Maltose had
no effect on accumulation of BLA or MBP. This finding is not
consistent with any mechanism involving changes in transcription/
translation. Furthermore, a transcriptional mechanism would be
expected to result in an equal magnitude switching phenotype for
all fusions in the library, not a variable switching phenotype for
just a select few. The effect of mutations designed to alter sugar
specificity and affinity indicate that a specific sugar-protein
interaction is required for the increase in production. This
evidence discounts a role for the osmolyte effect and also does
not support a mechanism involving changes in transcription/
translation.
Ligand-induced thermodynamic stabilization is a possible
mechanism for the observed increase in cellular accumulation in
the presence of ligand. For example, Foit et al. found that when a
variety of test proteins were inserted into BLA, the test protein’s
thermostability predicted the penicillin V resistance conferred by
the fusion [15]. Although the study did not address ligand binding
per se, mutations in the test protein that increased thermostability
also increased the accumulation level of the protein and the
conferred MIC relative to that of fusions made with the wild type
protein. When the insert protein was immunity protein 7, an
increase in accumulation level resulted in an equivalent increase in
MIC (R
2=0.60). A mutation causing a 6 kJ/mol increase in
stability (DDGu) caused a 2.7-fold increase in accumulation and a
2.7-fold increase in MIC, on average. However, for other proteins,
an equivalent stabilization resulted in a considerably smaller
increase in MIC. For granulocyte stimulating factor, a 10 kJ/mol
increase in stability only resulted in about a 1.4-fold increase in
MIC. Thus, for fusions of proteins with BLA, the relative effect of
stabilization on accumulation levels and MIC depends on the
identity of the fusion partner (and likely the topography of the
fusion).
Although we have not yet measured the thermodynamic
stability of the phenotypic switches, ligand-induced thermody-
namic stabilization by itself cannot explain our results. First, MBP
is thermodynamically stabilized 235 kJ/mol by binding to
maltose [16], yet, its accumulation was not altered by growing
the cells in the presence of maltose. Second, any fusion protein in
which the MBP domain retains the ability to bind maltose would
be thermodynamically stabilized by maltose-binding, yet most
such fusions are not phenotypic switches. Confounding factors
include the fact these two domain proteins are unlikely to fit the
simple two-state model of protein folding and the high likelihood
that the thermodynamic stability of the BLA domain of most
fusions may be partially or even entirely independent of the state of
MBP domain. Perhaps, phenotypic switches are comprised of the
small subset of fusions in which the thermodynamic stability of the
BLA domain is linked to the MBP domain – a hypothesis that we
intend to test in future experiments.
Any mechanism that increases the rate of achieving the folded
state or decreases the rate at which the protein is degraded would
cause increased accumulation. Thus, ligand-induced folding and a
ligand-induced decrease in the rate of proteolytic degradation of
the phenotypic switches are additional, non-mutually exclusive
mechanisms that could contribute to a ligand-dependent increase
in accumulation. Regarding the latter mechanism, the cpBLA
domains found in the phenotypic switches might expose
unstructured loops (known protease substrates [17,18]) due to
distortion of the wild-type fold upon fusion to MBP. Maltose-
binding to the fully folded protein could modulate the availability
of these or other proteolytic-sensitive sites on the protein though
maltose-induced conformational changes in the protein. Such a
protein could be considered to be a type of allosteric protein with
maltose-binding causing conformational changes that affect the
distant, proteolytic sensitive site. Alternatively, maltose binding
might enhance the folding rate such that the phenotypic switches
can fold to a proteolytic resistance form before they acted on by a
protease. Maltose might increase the folding rate of the protein
through the stabilization of intermediates along the folding
pathway. If such intermediates sequester protease-susceptible sites,
this could explain the increased accumulation of the protein in the
presence of maltose.
Regardless of the mechanism, the prevalence of phenotypic
switches in our library of non-homologously recombined genes has
important implications for switch construction and switch
Gene Fusions Confer a Switching Phenotype to Cells
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the cells (e.g. as a cellular reporter of effector concentration or as a
selective therapeutic protein), then the proteins do not necessarily
need to behave as allosteric switch in vitro to be useful. Thus, these
phenotypic switches represent an important class of switch proteins
for in vivo applications such as protein therapeutics. For example,
we recently engineered a switch that renders human colon and
breast cancer cells susceptible to a prodrug in a cancer marker-
dependent fashion [19]. The switch (called Haps59) consisted of a
fusion between a yeast cytosine deaminase (an enzyme that can
activate a prodrug) and the CH1 domain of the human p300
protein, a domain that can bind to the cancer marker HIF-1a.
The gene encoding this switch selectively conferred increased
susceptibility to the prodrug in cells that accumulated HIF-1a.
This increased prodrug susceptibility correlated with increased
accumulation of Haps59, analogous to how ampicillin resistance
correlated with increase switch accumulation in the data reported
here. Haps59 is thus a phenotypic switch.
Our isolation of many phenotypic switches in the work
presented here suggests that this type of switches is at least as
common as allosteric switches in libraries created by our
recombination strategy. However, phenotypic switches can only
be readily identified through selection strategies that select for the
switching phenotype. For example, screens involving assays of cell
lysates for effector-dependent activity, like we had previously used
to identify maltose-activated b-lactamases, will miss these
potentially useful proteins [2,3,4]. On the other hand, if switches
with in vitro switching activity are desired, selections based on
conferring a switching phenotype to cells warrant a secondary
screen to evaluate switching in an in vitro setting in order to
eliminate switches that function solely through an effector-
dependent increase in switch accumulation.
Materials and Methods
Strains
The phenotypic switches were discovered using E. coli strain
RH22 [5]. Electromax DH5a-E electro-competent cells were
purchased from Invitrogen. The malE knockout strain PM9F9 [20]
was used for protein purification of Ph8 and c4. DH5a-E was used
for the production of BLA.
Selection, isolation and identification of phenotypic
switches and control fusion
Selection of cells from a two-tiered selection system was
described in Sohka et al. [5]. The MICAmp of these colonies (34
total) was determined in the presence and absence of maltose.
Colonies with .2-fold MICAmp difference in the liquid culture
MICAmp assays (see below) were sequenced; the sequencing data
was poor in every case, suggesting the presence of multiple
pDIMC8-derived plasmids. Purified plasmid DNA from a
standard miniprep (concentration ,200–300 ng/mL) for each
colony was diluted 1000 fold into water and 1 mL was transformed
into DH5a-E cells (Invitrogen). The transformed bacteria were
spread on LB-agar plates supplemented with chloramphenicol
(Cm) (50 mg/mL), isopropyl-b-D-thiogalactopyranoside (IPTG)
(300 mM), maltose (5 mM) and Amp (4 mg/mL) and incubated
Figure 2. Effect of ligand concentration on MICAmp and
accumulation of phenotypic switches. (A) Western blot using anti-
BLA antibodies of the soluble fraction of cells expressing MBP317-347, Ph8
andsucroseswitch5–7 (arrow,,70 kDa).Cellswereculturedwith maltose
(mal), sucrose (suc), or neither sugar (2). (B) Correlation between the
MICAmp and the concentration of maltose added to the culture for cell
expressing MBP317-347 (N) or MBP317-347(W340A) (%). (C) Accu-
mulation levels dictate the MICAmp. Correlation between the
accumulation ratio (+maltose/2maltose), asmeasured by western
blot, and the MICAmp ratio (+maltose/2maltose) of cell expressing
MBP317-347 (N) or MBP317-347(W340A) (%). Different accumu-
lation ratios were obtained by culturing the cells in the presence
of different concentrations of maltose.
doi:10.1371/journal.pone.0027302.g002
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resulting colonies did not have the aforementioned problems.
The control fusion protein c4 was isolated by screening colonies
that survived the first tier of the switch selection procedure (i.e.
these library members have the ability to grow at high
concentrations of Amp in the presence of maltose). The effect of
maltose on the MICAmp was determined using the liquid culture
MICAmp assays (see below). Library members that did not show a
difference in the MICAmp were sequenced. Most members
contained a frame-shift mutation terminating the chimeric protein
shortly after the cpBLA insertion site; one member, however, had
an in-frame insertion. This member was named c4.
Liquid culture MICAmp assays
The optical density at 600 nm (OD600 nm) was measured for
each of the 10 ml overnight culture of cells expressing the
phenotypic switches in tryptone broth (10 g/L tryptone and 10 g/
L NaCl). Tryptone broth was used instead of LB for these
experiments since low-levels of maltodextrans have been detected
in yeast extract [2]. In each culture tube, approximately 1610
6
colony forming unit (based on OD600 nm) from the overnight
culture was added to 5 ml of tryptone medium containing Cm
(50 mg/ml), IPTG (300 mM), different concentrations of Amp, and
either the presence or absence of 5 mM maltose. The tubes were
incubated at 37uC in a shaker incubator. After 18 hours of
incubation, 200 ml was transferred to clear-bottom 96-well plates
and the OD600 nm was determined using a Molecular Devices
SpectraMax 386 plus. The MIC for Amp was defined as the lowest
concentration of Amp at which the OD600 nm was ,3% of the
OD600 nm in the absence of Amp.
Quantification of accumulation by western blotting
From the cultures used to determine MICAmp (see above),
6.8610
8 cells (based on OD600 nm) were collected and pelleted by
centrifugation at 4500 g for 10 min at 4uC and resuspended in
250 mL of Bugbuster (Novagen) supplemented with rlysozyme
(Novagen, 1 KU per 1 mL), benzonase nuclease (Novagen, 25 U
per 1 mL) and protease inhibitors (Sigma). Cells were lysed for
30 min at room temperature, centrifuged at 20,000 g for 30 min
at 4uC, then the soluble fraction was transferred into a new 1.5 ml
tube. The soluble fractions were loaded onto a 4–12% Bis-Tris Gel
(Invitrogen) and electrophoresed for 45 minutes at 190 V. Proteins
were transferred to PVDF membrane (Bio-Rad) at 15 V for
30 minutes using a semi-dry transfer cell (Bio-Rad).
The membrane was processed following the guidelines for the
SNAP-ID system (Millipore). The membrane was blocked with
30 mL 0.2% milk in Tris buffered saline, 0.05% Tween 20 (TBST)
and incubated with 1 mL of anti-BLA poly-clonal primary
antibody (Chemicon) in 3 mL of TBST for 10 min. For detection
of MBP, 1 mL of anti-MBP poly-clonal primary antibody
(Chemicon) was diluted in 3 mL of TBST and applied to the
membrane for 10 min. After washing three times with 30 mL of
TBST, the membrane was incubated with 0.5 mL of the secondary
antibody (goat-antirabbit, Bio-Rad) in 3 mL TBST for 10 min
followed by washing with 30 mL TBST 3 times. The blot was
incubated with 1 mL of WesternC substrate and enhancer (Bio-
Rad) for 3 min and imaged using a ChemiDoc XRS imaging
system (Bio-Rad). Quantification of the intensity of bands
corresponding to the amount of the proteins was performed using
Quantity One software (Bio-Rad).
Protein purification
For proteins containing an MBP domain, purification occurred
via an amylose column. Plasmids pDIMC8-RHPh8, pDIMC8-
RHPhc4, and pDIMC8-MBP317-347 were each transformed into
malE
2 E. coli strain PM9F9 for expression; pDIMC8-MBP was
transformed into DH5a-E. To produce each protein, one liter
ZYM-5052 media [21] containing 50 mg/ml Cm and 5 mM
maltose was inoculated with 2% overnight LB culture and shaken
at 37uC. The culture was induced with 300 mM IPTG when the
OD600 nm reached 0.6 and incubated at 25uC for 16 hours.
Pelleted cells were resuspended in 20 mL 50 mM sodium
phosphate and 250 mM NaCl and lysed by French press. The
soluble fraction was recovered by twice spinning the lysate at
20,000 g for 30 min and filtering the supernatant through a
0.45 mm syringe filter. The protein was purified using an amylose
affinity column (New England Biolabs). Protein was eluted with
10 mM maltose and was dialyzed for 48 hrs at 4uC against three
liters of 100 mM NaCl, 50 mM sodium phosphate buffer in a
10,000 MWCO dialysis cassette (Pierce), changing the dialysis
buffer after 24 hrs. Protein was concentrated in 20% glycerol,
100 mM NaCl, 50 mM sodium phosphate buffer using 10,000
MWCO spin columns (Amicon). Protein was stored in aliquots at
220uC.
For TEM-1 BLA, plasmid pDIMC8-BLA was transformed into
DH5a-E. One liter ZYM-5052 media [21] containing 50 mg/ml
Cm was inoculated with 5 mL overnight LB culture and shaken at
37uC. The culture was induced with 1 mM IPTG when the
OD600 nm reached 0.6 and incubated at 37uC for 16 hours.
Pelleted cells were resuspended in 15 mL 50 mM sodium
phosphate and 250 mM NaCl and lysed by French press. The
soluble fraction was recovered and the protein was purified using
an m-aminophenylboronic acid-agarose affinity column (Sigma).
Protein was eluted with 0.5 M boric acid, 0.5 M NaCl, pH 7.0.
Protein was concentrated and buffer-exchanged using 0.05 M
Tris, 1.5 M NaCl and 10,000 MWCO spin columns (Amicon).
Protein was then further purified using an Akta FPLC, with a
HiPrep Q FF 16/10 anion exchange column. Protein was again
concentrated and buffer exchanged with 50 mM phosphate buffer,
100 mM NaCl, 10% glycerol using 10,000 MWCO spin columns
(Amicon). Protein was stored in aliquots at 220uC.
The purities of all proteins were estimated by coomassie blue
staining of sodium dodecyl sulphate-polyacrylamide gel electro-
phoresis gels. The purities of Ph8, c4, MBP317-347 and MBP
were greater than 95%. Protein concentrations were measured
using a Nanodrop spectrophotometer at 280 nm.
Enzyme kinetic characterization
Hydrolysis of ampicillin was measured at 37uC in the presence
of 10 mM sodium phosphate buffer, pH 7.0. The concentrations
of Ph8 and c4 were 15 nM and 2 nM, respectively. The
concentration of substrate was varied from 100 mM to 400 mM.
Enzyme stocks were incubated with or without maltose for 1 hr at
4uC. After a mixture of water, buffer and ampicillin had reached
the desired temperature, 10 mL of enzyme was added to the
cuvette and the absorbance at 240 nm was recorded using a
Cary50 UV-VIS spectrophotometer. The initial rate of reaction
was used to calculate the kinetic constants via Eadie-Hofstee plots.
Although the calculated value of Km for c4 indicates that the Km
for c4 could be more accurately determined using experiments
with lower concentrations of ampicillin, the experiments as
performed are sufficient for demonstrating the lack of effect of
maltose on the kinetic parameters.
Thermal unfolding
Denaturation as a function of temperature of MBP, BLA,
MBP317-347, Ph8 and c4 was examined using circular dichroism
(CD) spectroscopy. Protein samples were incubated with and
Gene Fusions Confer a Switching Phenotype to Cells
PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27302without 5 mM maltose for 1 hr at 4uC prior to thermal
denaturation. CD measurements at 222 nm were recorded using
a Jasco J-710 CD Spectropolarimeter (Easton, MD). The
denaturation measurements were carried out using a quartz
cuvette (pathlength of 0.1 cm) in 30 mM sodium phosphate buffer
(pH 7.0) at 0.5 mg/mL protein. CD absorbance was collected
from 25–85uC at a temperature ramp rate of 1uC/min and a
bandwidth of 1 nm. The background due to the buffer was
measured and subtracted from the sample absorbance. For
comparison of the results, the data were normalized and fitted
to a two-state unfolding model [22].
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